184 related articles for article (PubMed ID: 37986009)
1. Identifying individualized prognostic signature and unraveling the molecular mechanism of recurrence in early-onset colorectal cancer.
Yang J; Zhao Y; Yuan R; Wang Y; Wang S; Chang Z; Zhao W
Eur J Med Res; 2023 Nov; 28(1):533. PubMed ID: 37986009
[TBL] [Abstract][Full Text] [Related]
2. A novel nomogram based on cell cycle-related genes for predicting overall survival in early-onset colorectal cancer.
Xiang M; Gao Y; Zhou Y; Wang M; Yao X
BMC Cancer; 2023 Jun; 23(1):595. PubMed ID: 37370046
[TBL] [Abstract][Full Text] [Related]
3. Unraveling a novel hippo-associated immunological prognostic signature: The contribution of SERPINE1 in facilitating colorectal cancer progression via the notch signaling pathway.
Su X; Wang X; Lai J; Mao S; Li H
Genomics; 2024 Mar; 116(2):110794. PubMed ID: 38224823
[TBL] [Abstract][Full Text] [Related]
4. An immune, stroma, and epithelial-mesenchymal transition-related signature for predicting recurrence and chemotherapy benefit in stage II-III colorectal cancer.
Cai D; Wang W; Zhong ME; Fan D; Liu X; Li CH; Huang ZP; Zhu Q; Lv MY; Hu C; Duan X; Wu XJ; Gao F
Cancer Med; 2023 Apr; 12(7):8924-8936. PubMed ID: 36629124
[TBL] [Abstract][Full Text] [Related]
5. Molecular characteristics of early-onset compared with late-onset colorectal cancer: A case controlled study.
Tang J; Peng W; Tian C; Zhang Y; Ji D; Wang L; Jin K; Wang F; Shao Y; Wang X; Sun Y
Int J Surg; 2024 May; ():. PubMed ID: 38742845
[TBL] [Abstract][Full Text] [Related]
6. Integrated multi-omics approach to distinct molecular characterization and classification of early-onset colorectal cancer.
Du M; Gu D; Xin J; Peters U; Song M; Cai G; Li S; Ben S; Meng Y; Chu H; Chen L; Wang Q; Zhu L; Fu Z; Zhang Z; Wang M
Cell Rep Med; 2023 Mar; 4(3):100974. PubMed ID: 36921601
[TBL] [Abstract][Full Text] [Related]
7. A qualitative transcriptional signature for predicting the biochemical recurrence risk of prostate cancer patients after radical prostatectomy.
Li X; Huang H; Zhang J; Jiang F; Guo Y; Shi Y; Guo Z; Ao L
Prostate; 2020 Apr; 80(5):376-387. PubMed ID: 31961962
[TBL] [Abstract][Full Text] [Related]
8. Identification of differentially expressed genes and splicing events in early-onset colorectal cancer.
Marx OM; Mankarious MM; Koltun WA; Yochum GS
Front Oncol; 2024; 14():1365762. PubMed ID: 38680862
[TBL] [Abstract][Full Text] [Related]
9. A Liquid Biopsy Signature for the Detection of Patients With Early-Onset Colorectal Cancer.
Nakamura K; Hernández G; Sharma GG; Wada Y; Banwait JK; González N; Perea J; Balaguer F; Takamaru H; Saito Y; Toiyama Y; Kodera Y; Boland CR; Bujanda L; Quintero E; Goel A
Gastroenterology; 2022 Nov; 163(5):1242-1251.e2. PubMed ID: 35850198
[TBL] [Abstract][Full Text] [Related]
10. Transcriptomic landscape of early age onset of colorectal cancer identifies novel genes and pathways in Indian CRC patients.
Singh MP; Rai S; Singh NK; Srivastava S
Sci Rep; 2021 Jun; 11(1):11765. PubMed ID: 34083590
[TBL] [Abstract][Full Text] [Related]
11. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
[TBL] [Abstract][Full Text] [Related]
12. Identification of ANXA1 as a potential prognostic biomarker and correlating with immune infiltrates in colorectal cancer.
Liang Z; Li X
Autoimmunity; 2021 Mar; 54(2):76-87. PubMed ID: 33596760
[TBL] [Abstract][Full Text] [Related]
13. A Transcriptome and Methylome Study Comparing Tissues of Early and Late Onset Colorectal Carcinoma.
Kibriya MG; Raza M; Quinn A; Kamal M; Ahsan H; Jasmine F
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430738
[TBL] [Abstract][Full Text] [Related]
14. Sporadic early-onset colorectal cancer is a specific sub-type of cancer: a morphological, molecular and genetics study.
Kirzin S; Marisa L; Guimbaud R; De Reynies A; Legrain M; Laurent-Puig P; Cordelier P; Pradère B; Bonnet D; Meggetto F; Portier G; Brousset P; Selves J
PLoS One; 2014; 9(8):e103159. PubMed ID: 25083765
[TBL] [Abstract][Full Text] [Related]
15. A network-based gene expression signature informs prognosis and treatment for colorectal cancer patients.
Shi M; Beauchamp RD; Zhang B
PLoS One; 2012; 7(7):e41292. PubMed ID: 22844451
[TBL] [Abstract][Full Text] [Related]
16. Reduced expression of alanyl aminopeptidase is a robust biomarker of non-familial adenomatous polyposis and non-hereditary nonpolyposis colorectal cancer syndrome early-onset colorectal cancer.
Ha YJ; Shin YJ; Tak KH; Park JL; Kim JH; Lee JL; Yoon YS; Kim CW; Kim SY; Kim JC
Cancer Med; 2023 Apr; 12(8):10091-10104. PubMed ID: 36748835
[TBL] [Abstract][Full Text] [Related]
17. An individualized prognostic signature and multi‑omics distinction for early stage hepatocellular carcinoma patients with surgical resection.
Ao L; Song X; Li X; Tong M; Guo Y; Li J; Li H; Cai H; Li M; Guan Q; Yan H; Guo Z
Oncotarget; 2016 Apr; 7(17):24097-110. PubMed ID: 27006471
[TBL] [Abstract][Full Text] [Related]
18. Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer.
Li B; Cui Y; Diehn M; Li R
JAMA Oncol; 2017 Nov; 3(11):1529-1537. PubMed ID: 28687838
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology and biology of early onset colorectal cancer.
Venugopal A; Carethers JM
EXCLI J; 2022; 21():162-182. PubMed ID: 35221839
[TBL] [Abstract][Full Text] [Related]
20. Cross-talk of four types of RNA modification writers defines tumor microenvironment and pharmacogenomic landscape in colorectal cancer.
Chen H; Yao J; Bao R; Dong Y; Zhang T; Du Y; Wang G; Ni D; Xun Z; Niu X; Ye Y; Li HB
Mol Cancer; 2021 Feb; 20(1):29. PubMed ID: 33557837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
